|
García Hernández A, García-Vázquez E, Gómez Gómez J, Canteras M, Hernandez-Torres A, Ruiz Gómez J. [Predictive factors of ESBL versus non-ESBL Escherichia coli bacteraemia and influence of resistance on the mortality of the patients]. Med Clin (Barc). 2011 Jan 29;136(2):56-60. doi: 10.1016/j.medcli.2010.05.014. Epub 2010 Jul 31. Spanish. PubMed PMID: 20673680.
AÑO: 2011; IF: 1.385
|
20673680
|
Hernández-Torres A, García-Vázquez E, Laso-Ortiz A, Herrero-Martínez JA, Gómez-Gómez J. [Candida sp endocarditis. Experience in a third-level hospital and review of the literature]. Rev Esp Quimioter. 2013 Mar;26(1):51-5. Review. Spanish. PubMed PMID: 23546464.
AÑO: 2013; IF: 0.905
|
|
Hernández-Torres A, García-Vázquez E, Frías-Iniesta J, Herrero-Martínez JA, Gómez-Gómez J. Cutaneous leishmaniasis in a patient receiving infliximab. Scand J Infect Dis. 2013 Jul;45(7):567-9. doi: 10.3109/00365548.2012.752859. PubMed PMID: 23270475.
AÑO: 2013; IF: 1.64
|
|
García-Vázquez E, Moral-Escudero E, Hernández-Torres A, Canteras M, Gómez J, Ruiz J. What is the impact of a rapid diagnostic E-test in the treatment of patients with Gram-negative bacteraemia? Scand J Infect Dis. 2013 Aug;45(8):623-8. doi: 10.3109/00365548.2013.782102. PubMed PMID: 23596976.
AÑO: 2013; IF: 1.64
|
|
Hernández-Roca JJ, García-Vázquez E, Hernández A, Canteras M, Herrero JA, Cascales E, Mené-Fenor E, Gómez-Gómez J. [Bacteraemia at a second level hospital: epidemiological study, analysis of pronostic factors associated to mortality and economic cost estimation]. Rev Esp Quimioter. 2013 Jun;26(2):119-27. Spanish. PubMed PMID: 23817650.
AÑO: 2013; IF: 0.905
|